Metagenomi Therapeutics (MGX)
Metagenomi Therapeutics (MGX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- MGX last traded at $0.61 on 2026-11-19, -2.85% for the session.
- Metagenomi Therapeutics: market cap $23.21M.
- Over the past year MGX returned -61.88%, with a year-to-date return of -62.11%.